<DOC>
	<DOCNO>NCT00718029</DOCNO>
	<brief_summary>The purpose study measure concentration Raltegravir cerebrospinal fluid . The hypothesis : - Raltegravir concentration CSF measurable - Raltegravir concentration CSF remain constant , plasma concentration vary widely lead highly variable CSF-to-plasma ratio . - Following least 4 week Raltegravir-containing combination therapy , HIV RNA level CSF 50 copies/mL subject .</brief_summary>
	<brief_title>Cerebrospinal Fluid ( CSF ) Raltegravir Substudy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Enrollment raltegravir parent protocol UCSD . Willing undergo lumbar puncture . Able give inform consent . If cognitively impair , test administer ensure adequate comprehension consent document procedure . Relative absolute contraindication lumbar puncture , current coagulopathy , thrombocytopenia ( platelet &lt; 50,000/ÂµL ) , hemophilia , use anticoagulant medication . Psychiatric disease would interfere study participation , opinion investigator . No major opportunistic infection within 30 day . Moderate severe cognitive impairment . The propose study neuropsychological objective .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>Cerebrospinal Fluid</keyword>
	<keyword>Raltegravir</keyword>
	<keyword>Drug Concentrations</keyword>
</DOC>